<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01788826</url>
  </required_header>
  <id_info>
    <org_study_id>HH01</org_study_id>
    <nct_id>NCT01788826</nct_id>
  </id_info>
  <brief_title>Prophylactic Mesh to Reduce The Incidence of Ventral Hernia</brief_title>
  <official_title>Randomized Clinical Trial to Evaluate the Use of a Prophylactic Polypropylene Mesh To Reduce the Incidence of Ventral Hernias in Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henares University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henares University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of ventral hernias has remained inappropriately high. Any innovation in order&#xD;
      to reduce this incidence would be simply cost-effective. Although there is still some concern&#xD;
      about the use of mesh in clean-contaminated or contaminated surgery, based in our&#xD;
      experimental studies, we plan to use a mesh in the primary closure of abdominal incision to&#xD;
      prevent incisional hernias.&#xD;
&#xD;
      The investigators propose a clinical trial to assess a model to prevent the incisional hernia&#xD;
      after laparotomy to treat colorectal carcinoma is scheduled. A simple randomization is&#xD;
      scheduled: in the intervention group a prefascial large-pore low-weight 5 cm wide&#xD;
      polypropylene mesh is fixed covering the midline closure; in the control group a conventional&#xD;
      closure with a running suture of long-term absorbable material with a suture/wound length&#xD;
      ratio 4:1. The sample size was calculated with an estimated incidence of ventral hernia of&#xD;
      25% in the control group and 10% in the intervention group, 0,05 alfa and a 0,15 beta error.&#xD;
      The main goal is the appearance of a ventral hernia after 24 months of follow-up. Other&#xD;
      outcomes are wound complications and morbidity. Exclusion criteria are adult patients with a&#xD;
      previous ventral hernia, estimated survival of less than 6 months or hemodynamic instability&#xD;
      during surgery.&#xD;
&#xD;
      The diagnosis of ventral hernia will be assessed by clinical exploration on 3,6,12,18 and 24&#xD;
      months and abdominal CT controls at 6,12, and 24 months. The study will be statistically&#xD;
      evaluated with SPSS 18.0.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the incidence of ventral hernia between the 2 groups</measure>
    <time_frame>24 months</time_frame>
    <description>Compare the incidence of ventral hernias at the end of the second year follow-up in patients operated for laparotomy using two different methods of abdominal wall closure: one with mesh reinforcement and another one with no mesh reinforcement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of superficial surgical site infection</measure>
    <time_frame>30 days</time_frame>
    <description>Compare the incidence of superficial surgical site infection between the 2 groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of deep surgical site infection</measure>
    <time_frame>30 days</time_frame>
    <description>Compare the incidence of deep surgical site infection between the 2 groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seroma</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of postoperative seroma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>Register of postoperative complications, including pulmonary, fistula and postoperative ileum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>Prophylactic Mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of a prefascial polypropylene mesh when closing midline laparotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No prophylactic mesh closure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm the laparotomy of the patients are closed with a running absorbable suture without a mesh</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prophylactic mesh</intervention_name>
    <description>Closure of midline laparotomy using a prophylactic mesh. The midline is closed with a running absorbable monofilament suture with a suture/wound length ratio 4:1. The material is a monofilament uncoated suture made of poly-4hiydroxybutirate (Monomax, B.Braun) USP 1. Then, a prefascial large-pore low-weight 5 cm wide polypropylene mesh (Optilene Mesh Elastic, B.Braun) is fixed covering the midline closure. The mesh is fixed in the prefascial plane with absorbable monofilament interrupted sutures, USP 2/0.</description>
    <arm_group_label>Prophylactic Mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No prophylactic mesh closure</intervention_name>
    <description>Closure of midline laparotomy without mesh. The laparotomy is closed with a running absorbable monofilament suture with a suture/wound length ratio 4:1. The material is a monofilament uncoated suture made of poly-4hiydroxybutirate (Monomax, B.Braun) USP 1.</description>
    <arm_group_label>No prophylactic mesh closure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  More than 18 years old.&#xD;
&#xD;
          -  Patients operated with elective or emergency midline laparotomy with the diagnosis of&#xD;
             colorectal cancer.&#xD;
&#xD;
          -  Written informed consent or oral consent with the present of two witnesses who do not&#xD;
             participate as investigators in the trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dissemination of oncologic disease: all stage IV tumors with estimated survival less&#xD;
             than 3 months.&#xD;
&#xD;
          -  Simultaneous participation in another trial with interference of intervention and&#xD;
             outcome.&#xD;
&#xD;
          -  Withdrawn or missing written consent.&#xD;
&#xD;
          -  Mental condition rendering the subject incapable of understanding the nature, scope&#xD;
             and consequences of the trial.&#xD;
&#xD;
          -  Previous ventral hernia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel Ángel García-Ureña, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henares University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henares University Hospital</name>
      <address>
        <city>Coslada</city>
        <state>Madrid</state>
        <zip>28522</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Strzelczyk JM, Szymański D, Nowicki ME, Wilczyński W, Gaszynski T, Czupryniak L. Randomized clinical trial of postoperative hernia prophylaxis in open bariatric surgery. Br J Surg. 2006 Nov;93(11):1347-50.</citation>
    <PMID>17006977</PMID>
  </reference>
  <reference>
    <citation>Stringer RA, Salameh JR. Mesh herniorrhaphy during elective colorectal surgery. Hernia. 2005 Mar;9(1):26-8. Epub 2004 Sep 10.</citation>
    <PMID>15365881</PMID>
  </reference>
  <reference>
    <citation>Gutiérrez de la Peña C, Medina Achirica C, Domínguez-Adame E, Medina Díez J. Primary closure of laparotomies with high risk of incisional hernia using prosthetic material: analysis of usefulness. Hernia. 2003 Sep;7(3):134-6. Epub 2003 Apr 3.</citation>
    <PMID>12687426</PMID>
  </reference>
  <reference>
    <citation>O'Hare JL, Ward J, Earnshaw JJ. Late results of mesh wound closure after elective open aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2007 Apr;33(4):412-3. Epub 2006 Dec 11.</citation>
    <PMID>17164090</PMID>
  </reference>
  <reference>
    <citation>Bellón JM, López-Hervás P, Rodríguez M, García-Honduvilla N, Pascual G, Buján J. Midline abdominal wall closure: a new prophylactic mesh concept. J Am Coll Surg. 2006 Oct;203(4):490-7. Epub 2006 Aug 23.</citation>
    <PMID>17000392</PMID>
  </reference>
  <reference>
    <citation>Israelsson LA, Millbourn D. Closing midline abdominal incisions. Langenbecks Arch Surg. 2012 Dec;397(8):1201-7. doi: 10.1007/s00423-012-1019-4. Epub 2012 Nov 11. Review.</citation>
    <PMID>23143146</PMID>
  </reference>
  <reference>
    <citation>Díaz-Godoy A, García-Ureña MA, López-Monclús J, Vega Ruíz V, Melero Montes D, Erquinigo Agurto N. Searching for the best polypropylene mesh to be used in bowel contamination. Hernia. 2011 Apr;15(2):173-9. doi: 10.1007/s10029-010-0762-0. Epub 2010 Dec 9.</citation>
    <PMID>21152940</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>February 7, 2013</study_first_submitted>
  <study_first_submitted_qc>February 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2013</study_first_posted>
  <last_update_submitted>February 8, 2013</last_update_submitted>
  <last_update_submitted_qc>February 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henares University Hospital</investigator_affiliation>
    <investigator_full_name>Miguel A ngel Garci-a Urena</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Ventral hernia</keyword>
  <keyword>surgical meshes</keyword>
  <keyword>polypropylenes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>August 21, 2016</submitted>
    <returned>October 13, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

